Minodronic Acid

• CAT Number: R032424
• CAS Number: 180064-38-4
• Molecular Formula: C9H12N2O7P2
• Molecular Weight: 322.15
• Purity: ≥95%
• Synonyms: (1-Hydroxy-2-imidazo[1,2-a]pyridin-3-ylethylidene)bis-phosphonic acid;?Imidazo[1,2-a]pyridine, phosphonic acid deriv.; BPH 261; Bonoteo; ONO 5920; Recalbon; YH 529; YM 529
• Target: Apoptosis
• Storage: 2-8°C
• IUPAC Name: (1-hydroxy-2-imidazo[1,2-a]pyridin-3-yl-1-phosphonoethyl)phosphonic acid
• InChI: InChI=1S/C9H12N2O7P2/c12-9(19(13,14)15,20(16,17)18)5-7-6-10-8-3-1-2-4-11(7)8/h1-4,6,12H,5H2,(H2,13,14,15)(H2,16,17,18)
• InChIKey: VMMKGHQPQIEGSQ-UHFFFAOYSA-N
• SMILES: C1=CC2=NC=C(N2C=C1)CC(O)(P(=O)(O)O)P(=O)(O)O

Minodronic acid (Cat No.:R032424) is a third-generation nitrogen-containing bisphosphonate used for the treatment of osteoporosis. As a potent bone resorption inhibitor, it helps prevent bone loss and enhances bone density. Minodronic acid is commonly prescribed to postmenopausal women with osteoporosis and patients at risk of fractures. By inhibiting osteoclast activity, it reduces bone turnover and contributes to the maintenance of bone health.